XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

제공처:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (International Name):

levocetirizine dihydrochloride

약제 형태:

Oral Liquid

구성:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

관리 경로:

Oral

패키지 단위:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

처방전 유형:

(S2) Pharmacy Medicine

치료 징후:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

제품 요약:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

승인 상태:

Registered

승인 날짜:

2010-01-19